Insiders have been trading these 5 stocks: ((TEVA)), ((AMGN)), ((RITM)), ((FSLY)) and ((MDT)). Here is a breakdown of their recent trades and their value.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
In a notable transaction, Christine, the EVP and Head of U.S. Commercial at Fox, has made headlines by selling 30,000 shares of Teva Pharmaceutical stock. This significant sale was valued at $753,300, highlighting a strategic financial move within the pharmaceutical sector. The transaction reflects a considerable shift in stock holdings, potentially signaling a change in market dynamics or personal investment strategies.
Amgen has also witnessed a substantial stock transaction, with SVP & CCO Nancy A. Grygiel selling 3,139 shares. This sale amounted to an impressive $1,058,659, underscoring the high value of Amgen shares in the current market. Grygiel’s decision to sell could be interpreted as a response to market conditions or a personal financial strategy, sparking interest among investors and analysts alike.
Rithm Capital’s CLO, David Zeiden, has opted to sell 19,285 shares, generating $214,063 from the transaction. This move by Zeiden may indicate a strategic repositioning within the company or a response to broader market trends. The sale adds to the ongoing narrative of executive stock transactions, providing insights into the financial maneuvers of key company figures.
Fastly has seen a flurry of executive stock sales, with CTO Artur Bergman selling 27,999 shares for $286,429, President Scott R. Lovett selling 9,779 shares for $100,039, and CEO Charles Lacey III Compton selling 18,455 shares for $188,794. These transactions, totaling a significant number of shares, suggest a coordinated approach among Fastly’s leadership. The sales might reflect strategic financial planning or a response to the company’s current market position.
In another noteworthy transaction, Gregory L. Smith, EVP of Global Operations & Supply Chain at Medtronic, has sold 5,814 shares, amounting to $593,172. This sale highlights the ongoing trend of executive stock transactions within the industry, with Smith’s decision potentially influenced by market conditions or personal financial goals. The transaction adds to the broader picture of executive financial activities in the healthcare sector.